Prof. Lubomir Bodnar: Immunotherapy has brought a breakthrough in cervical cancer

Immunotherapy is entering very strongly into the treatment of many cancers, but especially in cervical cancer it has brought a breakthrough. Very good therapies are already registered for both first- and second-line treatment. Refunds, unfortunately, are not. This is a change expected and desired by both patients and doctors," Professor Lubomir Bodnar, director of the Siedlce Oncology Center, told Medexpress in an interview at the Women's Health Congress.